<DOC>
	<DOCNO>NCT01966237</DOCNO>
	<brief_summary>Acute kidney injury ( AKI ) occur 40 % child follow heart surgery . Serum creatinine ( Scr ) late biomarker AKI , rise 24-48 hour surgery . Thus , medicine excrete urine , AKI could potentially lead toxic level blood . Urinary biomarkers ability detect AKI earlier . Whether early detection AKI urinary biomarkers predict alter drug level unknown . Milrinone use improve heart function surgery , accumulate AKI result low blood pressure . Dose adjustment currently possible late rise SCr , base clinical parameter may lead clinically relevant under-dosing . Thus , study address important knowledge gap first use elevation AKI biomarker concentration anticipate increase milrinone level .</brief_summary>
	<brief_title>Milrinone Pharmacokinetics Acute Kidney Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Milrinone</mesh_term>
	<criteria>Undergoing cardiothoracic surgery cardiopulmonary bypass weight great 2500 gram ( 5 pound 8 ounce ) time surgery gestational age &gt; 36 week age less &lt; 1 year infant complex congenital heart disease use milrinone intraoperative postoperative period . Preexisting kidney disease ( structural functional abnormality ) determine Principal Investigator use aminoglycosides within 48 hour plan surgery cardiac arrest prior cardiac surgery extracorporeal membrane oxygenation prior cardiac surgery urinary tract infection prior surgery repair isolate atrial ventricular septal defect</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>